| __timestamp | ACADIA Pharmaceuticals Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 120000 | 26551000 |
| Thursday, January 1, 2015 | 61000 | 50286000 |
| Friday, January 1, 2016 | 17331000 | 81321000 |
| Sunday, January 1, 2017 | 124901000 | 159201000 |
| Monday, January 1, 2018 | 223807000 | 251247000 |
| Tuesday, January 1, 2019 | 339076000 | 306486000 |
| Wednesday, January 1, 2020 | 441755000 | 353874000 |
| Friday, January 1, 2021 | 484145000 | 365978000 |
| Saturday, January 1, 2022 | 517235000 | 401858000 |
| Sunday, January 1, 2023 | 726437000 | 482375000 |
Data in motion
In the competitive world of biotechnology, revenue growth is a key indicator of a company's success and potential. Over the past decade, Corcept Therapeutics Incorporated and ACADIA Pharmaceuticals Inc. have shown remarkable trajectories in their annual revenue growth. Starting in 2014, Corcept Therapeutics reported a modest revenue, but by 2023, it had surged by over 1,700%, reaching approximately $482 million. Meanwhile, ACADIA Pharmaceuticals, which began with a negligible revenue in 2014, experienced an exponential increase, culminating in a staggering $726 million by 2023, marking an impressive growth of over 6,000%.
This data highlights the dynamic nature of the biotech industry, where innovation and strategic advancements can lead to significant financial gains. Investors and industry enthusiasts should keep a close eye on these companies as they continue to navigate the ever-evolving landscape of pharmaceuticals.
Revenue Insights: Eli Lilly and Company and Corcept Therapeutics Incorporated Performance Compared
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs Corcept Therapeutics Incorporated
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or ACADIA Pharmaceuticals Inc.
Revenue Showdown: Viatris Inc. vs Corcept Therapeutics Incorporated
Revenue Insights: Catalent, Inc. and Corcept Therapeutics Incorporated Performance Compared
Exelixis, Inc. vs ACADIA Pharmaceuticals Inc.: Examining Key Revenue Metrics
Who Generates More Revenue? Ascendis Pharma A/S or ACADIA Pharmaceuticals Inc.
Revenue Insights: Pharming Group N.V. and ACADIA Pharmaceuticals Inc. Performance Compared
Comparing Revenue Performance: Corcept Therapeutics Incorporated or Geron Corporation?
Corcept Therapeutics Incorporated or Galapagos NV: Who Leads in Yearly Revenue?
Corcept Therapeutics Incorporated vs Celldex Therapeutics, Inc.: Examining Key Revenue Metrics
Who Generates More Revenue? ACADIA Pharmaceuticals Inc. or Merus N.V.